|
|||||
|
|
Cardiovascular Event Reduction Versus New-Onset Diabetes During Atorvastatin Therapy : Effect of Baseline Risk Factors for Diabetes |
|
| Authors: | David D. Waters Jennifer E. Ho S. Matthijs Boekholdt David A. DeMicco John J.P. Kastelein Michael Messig Andrei Breazna Terje R. Pedersen |
| Affiliation: | ? Division of Cardiology, San Francisco General Hospital and the University of California at San Francisco, San Francisco, California;† National Heart, Lung, and Blood Institute, Framingham Heart Study, Framingham, Massachusetts;‡ Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands;§ Pfizer, Inc., New York, New York;∥ Center for Preventive Medicine, Ullevål University Hospital, Oslo, Norway |
| Abstract: | |
| Keywords: | atorvastatin cardiovascular events diabetes statins |
| 本文献已被 ScienceDirect 等数据库收录！ | |